Print Page   |   Sign In   |   Register
Companies: Matinas Biopharma Holdings, Inc. (MTNB)

Company Profile


Matinas BioPharma is a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective broad spectrum therapeutics for the treatment of serious and life-threatening infections. The Company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable. The Company's lead drug candidate is MAT2203, an orally-administered, encochleated formulation of amphotericin B (a broad spectrum fungicidal agent). The Company has an open Investigational New Drug (IND) application for MAT2501, which is an orally-administered, encochleated formulation of amikacin (a broad spectrum aminoglycoside antibiotic agent) for acute bacterial infections, including non-tuberculous mycobacterium (NTM) and multi-drug resistant gram negative bacterial infections. For more information, please visit  


Contact Information

  • 1545 Route 206 South
  • Suite 302
  • Bedminster, NJ 07921


Financial Reporting/Disclosure

Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0001582554
Fiscal Year End 12/31
OTC Marketplace OTCQB

Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Mar 19, 2015
Incorporated In: DE, USA
Year of Inc. 2013
Employees 10 a/o Mar 23, 2016

Company Officers/Contacts

Roelof Rongen CEO
Jerry Jabbour President, General Counsel, EVP
Gary Gaglione Interim CFO
Abdel Fawzy EVP, Bus. Affairs
Douglas F. Kling Senior VP
Raphael J. Mannino CSO, CTO

Company Directors

Herbert Conrad Chairman
Stefano Ferrari
Roelof Rongen
James Scibetta
Adam Stern

Service Providers

Accounting/Auditing Firm
EisnerAmper LLP
111 Wood Avenue South
Suite 600
Iselin, NJ, 08830-2700
United States

Legal Counsel

Lowenstein Sandler LLP (NJ)
65 Livingston Avenue
Roseland, NJ, 07068
United States

Investor Relations Firm

Jenene Thomas Communications, LLC
48 Sky Manor Road, G4
Pittstown, NJ, 08867
United States


Community Search
Sign In